MANDRIANI, Barbara
MANDRIANI, Barbara
DIPARTIMENTO DI BIOSCIENZE , BIOTECNOLOGIE E AMBIENTE
1101MO Development of CAR T-cells for future treatment of NETs
2021-01-01 Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M.
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives
2021-01-01 Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C.
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications
2022-01-01 Lauricella, Eleonora; Mandriani, Barbara; Cavallo, Federica; Pezzicoli, Gaetano; Chaoul, Nada; Porta, Camillo; Cives, Mauro
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
2019-01-01 Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F.
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
2022-01-01 Mandriani, Barbara; Pellè, Eleonora; Mannavola, Francesco; Palazzo, Antonio; Marsano, Renè Massimiliano; Ingravallo, Giuseppe; Cazzato, Gerardo; Ramello, Maria Cecilia; Porta, Camillo; Strosberg, Jonathan; Abate-Daga, Daniel; Cives, Mauro
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
2021-01-01 Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S.
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
2019-01-01 Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1101MO Development of CAR T-cells for future treatment of NETs | 1-gen-2021 | Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M. | |
| Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives | 1-gen-2021 | Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C. | |
| Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications | 1-gen-2022 | Lauricella, Eleonora; Mandriani, Barbara; Cavallo, Federica; Pezzicoli, Gaetano; Chaoul, Nada; Porta, Camillo; Cives, Mauro | |
| DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors | 1-gen-2019 | Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F. | |
| Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors | 1-gen-2022 | Mandriani, Barbara; Pellè, Eleonora; Mannavola, Francesco; Palazzo, Antonio; Marsano, Renè Massimiliano; Ingravallo, Giuseppe; Cazzato, Gerardo; Ramello, Maria Cecilia; Porta, Camillo; Strosberg, Jonathan; Abate-Daga, Daniel; Cives, Mauro | |
| The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability | 1-gen-2021 | Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S. | |
| The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. | 1-gen-2019 | Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F. |